Sila Cetik

Sila Cetik

Auto-generated profile, based on publicly available information

Sila Cetik

Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Appetite
Verified
Journal Article
Closed access
SCSila Cetik
Sila Cetik
AAAylin Acikgoz
Aylin Acikgoz
BYBulent Okan Yildiz
Bulent Okan Yildiz

1 March 2022 in Turkish Journal of Parasitology
Verified
Journal Article
Closed access
TATuğçe Ünalan Altıntop
Tuğçe Ünalan Altıntop
NKNafiye Koç
Nafiye Koç
SÇSıla Çetik
Sıla Çetik
SNSerpil Nalbantoğlu
Serpil Nalbantoğlu
YAYakut Akyön
Yakut Akyön
SESibel Ergüven
Sibel Ergüven
Myiasis is the infestation of tissues with living larvae. Oral myiasis is an extremely rare form of the disease, with open mouth, unconsciousness, and poor oral hygiene being the predisposing factors. It is generally observed in the tropics or subtropics, as well as rural places with low socio-economic income. Mechanical removal and ivermectin are frequently used as treatments. Herein, we present a case of oral myiasis in a 69-year-old male intubated patient with myocardial infarction. Multiple larvae were observed in the mouth and mechanically removed. With the microscopic investigation, the larvae were identified as Phormia regina (Meigen) (Diptera: Calliphoridae), which is extremely rare globally. For preventing oral myiasis, good patient care, good sanitary practice for oral health, efficient treatment of dental diseases, and fly population control, usage of masks for the risk groups are recommended.

30 June 2023 in Acta Medica
Verified
Journal Article
Open access
PDF file
HBHatice Bolek
Hatice Bolek
SCSila Cetik
Sila Cetik
FCFurkan Ceylan
Furkan Ceylan
EBErtugrul Cagri Bolek
Ertugrul Cagri Bolek
OUOguz Abdullah Uyaroglu
Oguz Abdullah Uyaroglu
MTMine Durusu Tanriover
Mine Durusu Tanriover
Background: Heart failure (HF) is a common disease which is one of the most common causes of hospitalization. Although mortality rates are decreasing, readmission rates are still quite high. Objectives: We aimed to investigate the risk factors for readmission and death in patients who were hospitalized due to HF. Design and Setting: Retrospective study, Hacettepe University, Ankara, Turkey Methods: Patients hospitalized between 1 January 2014 to 31 December 2018 with the primary diagnosis of HF were included. Outcome variables were risk factors for 30-day all- caused readmission, 30-day HF related readmission, mortality. Results: All-cause 30-day readmission rate was 34.8% and HF-related 30-day readmission rate was 21.2%. The factors associated with increased all-caused 30-day readmission were male gender, hyperlipidemia, chronic liver disease, malignancy. The factors associated with increased HF-related 30-day readmission were hyperlipidemia, chronic liver disease, inflammatory rheumatologic diseases, malignancy. Use of ACE-i was found to be protective against all-cause and HF-related 30-day readmission. Factors associated with mortality were ejection fraction <30%, chronic liver disease, acute kidney injury, hypoalbuminemia at the time of admission. Conclusions: Nearly one third of patients in this cohort who were hospitalized with a primary diagnosis of HF were readmitted in the following 30 days. Having certain chronic diseases and conditions were associated with an increased risk for readmission and mortality. These findings point out to the special needs of HF patients, who require a proactive, integrated and multidisciplinary management strategy to control the risk factors and to improve the inpatient and transitional stages in the hospital.